52 results
8-K
EX-99.1
BTAI
BioXcel Therapeutics Inc
14 Feb 24
Regulation FD Disclosure
7:00am
pandemic; risks associated with the increased scrutiny related to environmental, social and governance (ESG) m atters, its ability to commercialize
8-K
EX-10.1
BTAI
BioXcel Therapeutics Inc
8 Feb 24
Other Events
4:53pm
Adverse Change; provided, that for purposes of this Section 7.04(b), the impacts of the COVID-19 pandemic on the business, operations or financial
8-K
EX-99.1
BTAI
BioXcel Therapeutics Inc
14 Nov 23
Results of Operations and Financial Condition
12:00am
-attacks, if any; impacts from the COVID-19 pandemic; risks associated with the increased scrutiny relating to environmental, social and governance (ESG
8-K
EX-99.2
bo9o9z
10 Oct 23
Regulation FD Disclosure
7:06am
8-K
EX-99.1
72c54780v8h
10 Oct 23
Regulation FD Disclosure
7:06am
8-K
tzdwgdj6kqv
4 Oct 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
g77mz0nw9v60h3fls
14 Aug 23
BioXcel Therapeutics Reports Second Quarter 2023 Financial Results and Announces Strategic Reprioritization
7:20am
8-K
EX-99.1
bzfca0 b0yhsdj
8 May 23
BioXcel Therapeutics Reports First Quarter 2023 Financial Results and Recent Operational Highlights
8:30am
8-K
nv0c40tp0li6
20 Apr 23
Other Events
7:00am
8-K
EX-99.1
r5t vejt44qu
10 Nov 22
BioXcel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Operational Highlights
7:15am
8-K
8hhzh6xxlo iy
12 Sep 22
Other Events
7:00am
8-K
EX-99.1
l6jy8mqj79yxcf8
12 Sep 22
Other Events
7:00am